Dr. Claudia Benavente, assistant professor of Pharmaceutical Sciences and Developmental and Cell Biology, was awarded a $100,000 grant through the American Association for Cancer Research (AACR).  The AACR-Aflac Incorporated Career Development Award for Pediatric Cancer Research is awarded every year to a project believed to have significant impact in the field of pediatric cancer research and in recognition of the applicant’s potential as future leader in the field. Dr. Benavente is this year’s award recipient for her project aiming at elucidating the role of the chromatin remodeling protein UHRF1 as a potential therapeutic target for the treatment of osteosarcoma, a childhood cancer of the bone.